Annual Operating Expenses
$89.60 M
+$1.31 M+1.48%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual total operating expenses is $89.60 million, with the most recent change of +$1.31 million (+1.48%) on December 31, 2023.
- During the last 3 years, GYRE annual operating expenses has risen by +$34.17 million (+61.64%).
- GYRE annual operating expenses is now at all-time high.
Performance
GYRE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$20.30 M
-$896.00 K-4.23%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly total operating expenses is $20.30 million, with the most recent change of -$896.00 thousand (-4.23%) on September 30, 2024.
- Over the past year, GYRE quarterly operating expenses has dropped by -$10.79 million (-34.71%).
- GYRE quarterly operating expenses is now -34.71% below its all-time high of $31.09 million, reached on December 31, 2023.
Performance
GYRE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
GYRE Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.5% | -34.7% |
| 3 y3 years | +61.6% | +18.4% |
| 5 y5 years | +61.6% | +18.4% |
GYRE Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.6% | -34.7% | +28.2% |
| 5 y | 5-year | at high | +61.6% | -34.7% | +28.2% |
| alltime | all time | at high | +61.6% | -34.7% | +28.2% |
Gyre Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.30 M(-4.2%) |
| Jun 2024 | - | $21.19 M(+16.9%) |
| Mar 2024 | - | $18.12 M(-41.7%) |
| Dec 2023 | $89.60 M | $31.09 M(+71.8%) |
| Sep 2023 | - | $18.09 M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $23.28 M(+35.8%) |
| Mar 2023 | - | $17.14 M(+8.3%) |
| Dec 2022 | $88.29 M(+59.3%) | - |
| Mar 2022 | - | $15.83 M |
| Dec 2021 | $55.43 M | - |
FAQ
- What is Gyre Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Gyre Therapeutics?
- What is Gyre Therapeutics annual operating expenses year-on-year change?
- What is Gyre Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly operating expenses year-on-year change?
What is Gyre Therapeutics annual total operating expenses?
The current annual operating expenses of GYRE is $89.60 M
What is the all time high annual operating expenses for Gyre Therapeutics?
Gyre Therapeutics all-time high annual total operating expenses is $89.60 M
What is Gyre Therapeutics annual operating expenses year-on-year change?
Over the past year, GYRE annual total operating expenses has changed by +$1.31 M (+1.48%)
What is Gyre Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of GYRE is $20.30 M
What is the all time high quarterly operating expenses for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly total operating expenses is $31.09 M
What is Gyre Therapeutics quarterly operating expenses year-on-year change?
Over the past year, GYRE quarterly total operating expenses has changed by -$10.79 M (-34.71%)